Iovance Inventory Plunges as FDA Places Withhold on Lung Cancer Ogle After Affected person Loss of life

Iovance Biotherapeutics inventory used to be tumbling Wednesday after the Meals and Drug Administration positioned a clinical have on a cancer medication focus on following the death of a focus on patient.